Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Gatta

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Dermatological Treatment|September 25, 2018
Omalizumab in chronic spontaneous urticaria: steroid sparing effectAlessia Gatta, Loredana Della Valle, Anila Farinelli, et al.
Biomedicines|June 28, 2023
Insights from a Case of Good's Syndrome (Immunodeficiency with Thymoma)Roberto Paganelli, Michela Di Lizia, Marika D'Urbano, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|June 20, 2018
[Allergens in occupational allergy: risk management.]Mario Di Gioacchino, Luca Di Giampaolo, Alessia Gatta, et al.
Case Reports in Ophthalmology|August 11, 2020
Vernal Keratoconjunctivitis: A Case of Anti-IgE Treatment with Short-Lasting RemissionAlessia Gatta, Loredana Della Valle, Anila Farinelli, et al.
International Journal of Immunopathology and Pharmacology|June 9, 2016
Fluticasone/formoterol association favors long-lasting decrease in bronchial reactivity to methacholine and weekly PEF variabilitySara Cortese, Alessia Gatta, Loredana Della Valle, et al.
Clinical and Molecular Allergy : CMA|August 9, 2016
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c miceClaudia Petrarca, Emanuela Clemente, Valentina Amato, et al.
Expert Review of Clinical Immunology|April 29, 2020
Nanoparticle-based immunotherapy: state of the art and future perspectivesMario Di Gioacchino, Claudia Petrarca, Alessia Gatta, et al.
International Journal of Immunopathology and Pharmacology|December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficienciesClementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
Clinical and Molecular Allergy : CMA|December 21, 2021
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholderEster Di Agosta, Lorenzo Salvati, Monica Corazza, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Dermatological Treatment|September 25, 2018
Omalizumab in chronic spontaneous urticaria: steroid sparing effectAlessia Gatta, Loredana Della Valle, Anila Farinelli, et al.
Biomedicines|June 28, 2023
Insights from a Case of Good's Syndrome (Immunodeficiency with Thymoma)Roberto Paganelli, Michela Di Lizia, Marika D'Urbano, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|June 20, 2018
[Allergens in occupational allergy: risk management.]Mario Di Gioacchino, Luca Di Giampaolo, Alessia Gatta, et al.
Case Reports in Ophthalmology|August 11, 2020
Vernal Keratoconjunctivitis: A Case of Anti-IgE Treatment with Short-Lasting RemissionAlessia Gatta, Loredana Della Valle, Anila Farinelli, et al.
International Journal of Immunopathology and Pharmacology|June 9, 2016
Fluticasone/formoterol association favors long-lasting decrease in bronchial reactivity to methacholine and weekly PEF variabilitySara Cortese, Alessia Gatta, Loredana Della Valle, et al.
Clinical and Molecular Allergy : CMA|August 9, 2016
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c miceClaudia Petrarca, Emanuela Clemente, Valentina Amato, et al.
Expert Review of Clinical Immunology|April 29, 2020
Nanoparticle-based immunotherapy: state of the art and future perspectivesMario Di Gioacchino, Claudia Petrarca, Alessia Gatta, et al.
International Journal of Immunopathology and Pharmacology|December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficienciesClementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
Clinical and Molecular Allergy : CMA|December 21, 2021
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholderEster Di Agosta, Lorenzo Salvati, Monica Corazza, et al.
Pageof 1